Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States

Wanjun Bai,1 Xue Sun,1 Bo Qiu,1 Caihui Guo,1 Haojing Song,1 Yiting Hu,1 Xueyuan Zhang,2 Peihua Yin,3 Xiaoru Wang,3 Zhanjun Dong1 1Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People’s Republic of China; 2Center for Clinical Pharmacol...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Bai W, Sun X, Qiu B, Guo C, Song H, Hu Y, Zhang X, Yin P, Wang X, Dong Z
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Dove Medical Press 2024-06-01
Rangatū:	Drug Design, Development and Therapy
Ngā marau:	apremilast psoriasis pharmacokinetics bioequivalence safety.
Urunga tuihono:	https://www.dovepress.com/pharmacokinetics-and-bioequivalence-of-apremilast-tablets-in-chinese-h-peer-reviewed-fulltext-article-DDDT
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!